These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22395713)

  • 21. Seroprevalence of herpes simplex virus-2 infection among women seeking medical care for signs and symptoms of vaginitis.
    Ross SE; Carter B; Lambert S
    Herpes; 2009 Jan; 15(3):46-50. PubMed ID: 19306602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatients.
    Andréoletti L; Piednoir E; Legoff J; Brodard V; Beguinot I; Strady C; Rouger C; Piketty C; Si-Mohamed A; Kazatchkine MD; Malkin JE; Bélec L
    J Clin Microbiol; 2005 Aug; 43(8):4215-7. PubMed ID: 16081982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004.
    Schillinger JA; McKinney CM; Garg R; Gwynn RC; White K; Lee F; Blank S; Thorpe L; Frieden T
    Sex Transm Dis; 2008 Jun; 35(6):599-606. PubMed ID: 18418295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho.
    Rabenau HF; Lennemann T; Kircher C; Gürtler L; Staszewski S; Preiser W; McPherson P; Allwinn R; Doerr HW
    Sex Transm Dis; 2010 Jul; 37(7):454-9. PubMed ID: 20531031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department.
    Patel EU; Laeyendecker O; Hsieh YH; Rothman RE; Kelen GD; Quinn TC
    J Clin Virol; 2016 Jul; 80():93-7. PubMed ID: 27232485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of herpes simplex virus type-2 among patients attending the Sexually Transmitted Infections Clinic in Jos, Nigeria.
    Agabi YA; Banwat EB; Mawak JD; Lar PM; Dashe N; Dashen MM; Adoga MP; Agabi FY; Zakari H
    J Infect Dev Ctries; 2010 Oct; 4(9):572-5. PubMed ID: 21045370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Herpes simplex virus type 1 and 2 in Switzerland].
    Laubereau B; Zwahlen M; Neuenschwander B; Heininger U; Schaad UB; Desgrandchamps D
    Schweiz Med Wochenschr; 2000 Feb; 130(5):143-50. PubMed ID: 10701231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.
    Ameli N; Bacchetti P; Morrow RA; Hessol NA; Wilkin T; Young M; Cohen M; Minkoff H; Gange SJ; Greenblatt RM
    AIDS; 2006 Apr; 20(7):1051-8. PubMed ID: 16603858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
    Wald A; Ashley-Morrow R
    Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unexpected high prevalence of herpes simplex virus (HSV) type 2 seropositivity and HSV genital shedding in pregnant women living in an East Paris suburban area.
    LeGoff J; Saussereau E; Boulanger MC; Chemin C; Si-Mohamed A; Bélec L; Maisonneuve L
    Int J STD AIDS; 2007 Sep; 18(9):593-5. PubMed ID: 17785000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genital shedding of herpes simplex virus among men.
    Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
    J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
    Jonsson MK; Levi M; Rudén U; Wahren B
    Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of genital herpes - recent advances.
    Halioua B; Malkin JE
    Eur J Dermatol; 1999; 9(3):177-84. PubMed ID: 10210781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of genital herpes.
    Kinghorn GR
    J Int Med Res; 1994; 22 Suppl 1():14A-23A. PubMed ID: 8063020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies to herpes simplex virus 2 among homosexual men either positive or negative for human immunodeficiency viruses in Slovakia.
    Bystrická M; Gasparovicová L; Staneková D; Mokrás M; Soláriková L; Russ G
    Acta Virol; 2000; 44(3):163-7. PubMed ID: 11155359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.
    Strick LB; Wald A; Celum C
    Clin Infect Dis; 2006 Aug; 43(3):347-56. PubMed ID: 16804851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
    Langenberg AG; Corey L; Ashley RL; Leong WP; Straus SE
    N Engl J Med; 1999 Nov; 341(19):1432-8. PubMed ID: 10547406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris.
    Janier M; Lassau F; Bloch J; Spindler E; Morel P; Gérard P; Aufrère A
    Int J STD AIDS; 1999 Aug; 10(8):522-6. PubMed ID: 10471101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus type 2 infection among commercial sex workers in Kunming, Yunnan Province, China.
    Ngo TD; Laeyendecker O; Li C; Tai H; Cui M; Lai S; Quinn TC
    Int J STD AIDS; 2008 Oct; 19(10):694-7. PubMed ID: 18824623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
    Morrow RA; Friedrich D; Meier A; Corey L
    BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.